UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 134

Sortiert nach

Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma

Cochrane database of systematic reviews, 2012-08 (8), p.CD003915

2012

Volltextzugriff (PDF)

Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas

Oncotarget, 2018-03, Vol.9 (24), p.17093-17103

2018

Volltextzugriff (PDF)

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Radiotherapy and oncology, 2022-03, Vol.168, p.75-82

2022

Volltextzugriff (PDF)

Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

Radiotherapy and oncology, 2023-10, Vol.187, p.109806-109806, Article 109806

2023

Volltextzugriff (PDF)

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

Radiotherapy and oncology, 2023-01, Vol.178, p.109426-109426, Article 109426

2023

Volltextzugriff (PDF)

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

Cochrane database of systematic reviews, 2005-07 (3), p.CD002225

2005

Volltextzugriff (PDF)

Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy

Breast (Edinburgh), 2023-12, Vol.72, p.103578-103578, Article 103578

2023

Volltextzugriff (PDF)

Standardized Total Average Toxicity Score: A Scale- and Grade-Independent Measure of Late Radiotherapy Toxicity to Facilitate Pooling of Data From Different Studies

International journal of radiation oncology, biology, physics, 2012-03, Vol.82 (3), p.1065-1074

2012

Volltextzugriff (PDF)

Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer

Cochrane database of systematic reviews, 2012-12, Vol.12, p.CD007406

2012

Volltextzugriff (PDF)

Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity

Clinical and translational radiation oncology, 2019-09, Vol.18, p.1-8

2019

Volltextzugriff (PDF)

Variation in Telangiectasia Predisposing Genes Is Associated With Overall Radiation Toxicity

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (4), p.1031-1036

2012

Volltextzugriff (PDF)

Antimicrobial therapy to prevent or treat oral mucositis

The Lancet infectious diseases, 2003-07, Vol.3 (7), p.405-412

2003

Volltextzugriff (PDF)

Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer

Cochrane database of systematic reviews, 2010-01 (1), p.CD007406

2010

Volltextzugriff (PDF)

20-year retrospective review of medium dose rate intracavitary brachytherapy in VAIN3

Gynecologic oncology, 2007-07, Vol.106 (1), p.105-111

2007

Volltextzugriff (PDF)

XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients

International journal of radiation oncology, biology, physics, 2015-08, Vol.92 (5), p.1084-1092

2015

Volltextzugriff (PDF)

Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo

International journal of cancer, 2014-03, Vol.134 (5), p.1102-1111

2014

Volltextzugriff (PDF)

Development and validation of a predictive risk model for acute skin toxicity in patients undergoing breast radiotherapy

European journal of surgical oncology, 2017-05, Vol.43 (5), p.S7-S7

2017

Volltextzugriff (PDF)

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

Frontiers in oncology, 2022-10, Vol.12, p.937934-937934

2022

Volltextzugriff (PDF)

Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity

Radiotherapy and oncology, 2012-12, Vol.105 (3), p.289-295

2012

Volltextzugriff (PDF)

Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort

EBioMedicine, 2022-10, Vol.84, p.104269, Article 104269

2022

Volltextzugriff (PDF)

Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort

Advances in radiation oncology, 2022-05, Vol.7 (3), p.100890-100890, Article 100890

2022

Volltextzugriff (PDF)

The REQUITE-AB study: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in breast cancer patients

European journal of surgical oncology, 2016-05, Vol.42 (5), p.S5-S5

2016

Volltextzugriff (PDF)

Are depressive symptoms more common among British South Asian patients compared with British White patients with cancer? A cross-sectional survey

BMJ open, 2013-01, Vol.3 (6), p.e002650

2013

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(122)

Publikationsform

Artikel
(132)
Bücher
(2)

Sprache

Englisch
(134)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(91)
Life Sciences & Biomedicine
(85)
Humans
(79)
Female
(56)
Oncology
(52)
Middle Aged
(35)
Adult
(29)
Male
(29)
Biological And Medical Sciences
(27)
Aged
(25)
Medical Sciences
(25)
Radiotherapy
(24)
Chemotherapy
(21)
Radiology, Nuclear Medicine & Medical Imaging
(21)
Cancer
(17)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Hematology, Oncology And Palliative Medicine
(13)
Patients
(13)
Breast Neoplasms - Radiotherapy
(11)
Combined Modality Therapy
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial

Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma

Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy

Standardized Total Average Toxicity Score: A Scale- and Grade-Independent Measure of Late Radiotherapy Toxicity to Facilitate Pooling of Data From Different Studies

Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer

Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity

Variation in Telangiectasia Predisposing Genes Is Associated With Overall Radiation Toxicity

Antimicrobial therapy to prevent or treat oral mucositis

Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer

20-year retrospective review of medium dose rate intracavitary brachytherapy in VAIN3

XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients

Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo

Development and validation of a predictive risk model for acute skin toxicity in patients undergoing breast radiotherapy

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity

External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort

Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort

Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort

The REQUITE-AB study: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in breast cancer patients

Are depressive symptoms more common among British South Asian patients compared with British White patients with cancer? A cross-sectional survey

Suchergebnisse filtern